Point72 Hong Kong LTD Revolution Medicines, Inc. Transaction History

Point72 Hong Kong LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$14.54 - $27.17 $29,050 - $54,285	1,998 New	1,998 $39,000
Q1 2022 May 16, 2022	SELL	$17.31 - $26.4 $43,015 - $65,604	-2,485 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$24.35 - $33.7 $40,834 - $56,514	-1,677 Reduced 40.29%	2,485 $63,000
Q3 2021 Nov 15, 2021	BUY	$23.95 - $33.41 $99,679 - $139,052	4,162 New	4,162 $114,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.